1. Home
  2. Medical Research
  3. Gaithersburg, MD
  4. Caring Cross

Caring Cross

Caring Cross has an America's Best Score of 51 out of 100, based on its 2024 Form 990, below the 60-point bar to be ranked.

  • Gaithersburg, MD
  • Tax-exempt since 2020
  • EIN: 81-5088460
caringcross.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
51OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Caring Cross is a 501(c)(3) organization, classified under Medical Research (NTEE H99). Contributions are tax-deductible.

910 Clopper Rd Ste 200S, Gaithersburg, MD 20878-1361

Among the 3 scored medical research organizations in Gaithersburg, Caring Cross holds 12.2 months of operating reserves (peer median 12.2 months), runs a typical yearly deficit of 25.1% (peers: deficit of 4.0%), and has grown spending 60.9% a year (peers: grown spending 19.0% a year).

In fiscal year 2024 it reported $6,365,843 in revenue and $10,310,690 in expenses, with contributions making up 59.3% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

Caring Cross is focused upon accelerating the development and implementation of advanced medicines like car-t cell and STEM cell gene therapies. In partnership with like-minded stakeholders, Caring Cross develops and deploys technologies, systems and therapeutic candidates that improve the affordability and accessibility of these potentially life-saving therapies for all patients in need, everywhere.

Largest programs · fiscal year 2024

  • University of Delaware: Niimbl research development, and testbeds to help the nation prevent, prepare for and respond to coronavirus. $5,530,229 spent · 72.0% of program spending
  • Tome biosciences and Caring Cross inc. Research collaboration $1,365,313 spent · 17.8% of program spending
  • The regents of the university of California on behalf of its san francisco campus "ucsf": Complete the phase I iia clinical trial develop a commercial manufacturing process and develop a regulatory pathway plan for decentralized fda approval of the anti-hiv duocar-t cell product. $780,267 spent · 10.2% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 74¢ went to programs, 26¢ to management and 0¢ to fundraising.

  • Programs $7,675,809
  • Management $2,634,881
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score51 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves12.2 mo; 7.2 mo in cash8.5 / 25
Financial balance (median margin)−25.1%0 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth+60.9% / yr15 / 15
Track record6 years2.4 / 10
Debt load36.4% of assets4.7 / 10
Total50.6 → 51
Spending on programs
Not scored; America's Best needs 65%+
74%Meets

Compared with Gaithersburg peers

MeasureThis organizationPeer median
Operating reserves12.2 mo12.2 mo
Typical margin−25.1%−4.0%
Spending growth+60.9% / yr+19.0% / yr
Debt load36.4%30.8%

Peers: the 3 Gaithersburg medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$6,365,843Fiscal year 20242022: $2,984,74220222023: $17,750,32420232024: $6,365,8432024
Expenses$10,310,690Fiscal year 20242022: $3,984,82620222023: $4,767,20420232024: $10,310,6902024
Total assets$16,467,907Fiscal year 20242022: $1,942,18220222023: $15,530,16820232024: $16,467,9072024
Total liabilities$5,991,534Fiscal year 20242022: $364,09220222023: $983,56520232024: $5,991,5342024
Fiscal year ending December 2024
Revenue$6,365,843
Expenses$10,310,690
Net income−$3,944,847
Net assets$10,476,373

Notable sources of revenue

Percent of total revenue
Contributions$3,773,205
Program services$1,339,248
Investment income$373,031
Other (net)$880,359

Assets / debt

Total assets$16,467,907
Total liabilities$5,991,534
Net assets$10,476,373

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$17,750,324
Expenses$4,767,204
Net income$12,983,120
Net assets$14,546,603

Notable sources of revenue

Percent of total revenue
Contributions$2,243,444
Program services$15,470,452
Investment income$36,428
Other (net)$0

Assets / debt

Total assets$15,530,168
Total liabilities$983,565
Net assets$14,546,603

Compensation

Officers and key employees$390,704
Share of expenses8.2%
Fiscal year ending December 2022
Revenue$2,984,742
Expenses$3,984,826
Net income−$1,000,084
Net assets$1,578,090

Notable sources of revenue

Percent of total revenue
Contributions$2,899,434
Program services$79,125
Investment income$6,183
Other (net)$0

Assets / debt

Total assets$1,942,182
Total liabilities$364,092
Net assets$1,578,090

Compensation

Officers and key employees$495,154
Share of expenses12.4%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?